Your browser doesn't support javascript.
loading
Impact of COVID-19 pandemic on use of rituximab among children with difficult nephrotic syndrome.
Sinha, Rajiv; Marlais, Matko; Sarkar, Subhankar; Obukhova, Varvara; Lucchetti, Laura; Vasudevan, Anil; Chacon Jaimes, Diana Carolina; Weaver, Donald J; Stanczyk, Malgorzata; Lopez-Gonzalez, Mercedes; Schaefer, Franz; Tullus, Kjell.
Afiliación
  • Sinha R; Institute of Child Health, Kolkata, India. rajivsinha_in@yahoo.com.
  • Marlais M; Great Ormond Street Hospital, London, UK.
  • Sarkar S; Institute of Child Health, Kolkata, India.
  • Obukhova V; Nephrology Department, Veltischev Research and Clinical Institute for Pediatrics of the Pirogov Russian National Research Medical University, Moscow, Russia.
  • Lucchetti L; Bambino Gesù Children Hospital, Rome, Italy.
  • Vasudevan A; St Johns Hospital, Bengaluru, India.
  • Chacon Jaimes DC; Clinica FOSCAL, Bucaramanga, Colombia.
  • Weaver DJ; Atrium Health Levine Children's Hospital, Charlotte, NC, USA.
  • Stanczyk M; Polish Mother's Memorial Hospital Research Institute of Lodz, Lódz, Poland.
  • Lopez-Gonzalez M; University Hospital Valld'Hebron, Barcelona, Spain.
  • Schaefer F; Heidelberg University Hospital, Heidelberg, Germany.
  • Tullus K; Great Ormond Street Hospital, London, UK.
Pediatr Res ; 92(1): 3-5, 2022 07.
Article en En | MEDLINE | ID: mdl-34548632

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Síndrome Nefrótico Límite: Child / Humans Idioma: En Revista: Pediatr Res Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Síndrome Nefrótico Límite: Child / Humans Idioma: En Revista: Pediatr Res Año: 2022 Tipo del documento: Article País de afiliación: India